#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Malignant peritoneal neoplasm Hypochondroplasia Waldenstrom's macroglobulinaemia Hormone-dependent prostate cancer Breast cancer metastatic Acute lymphocytic leukaemia recurrent Spina bifida B-cell small lymphocytic lymphoma recurrent Neonatal asphyxia Neonatal alloimmune thrombocytopenia Leiomyosarcoma Burkitt's lymphoma Bladder cancer Neuroendocrine carcinoma metastatic More trials…

    Learn about Rare Diseases

    Mastocytosis – Trials in Disease Primary hyperoxaluria – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Hereditary motor and sensory neuropathy – Trials in Disease Haemophilia B with anti factor IX Short-bowel syndrome – Diagnostics Retinoblastoma – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Angiosarcoma recurrent – Life with Disease Pleomorphic leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMLENETUG Incb099280 Netupitant Triamcinolone Hexacetonide Sodium Fluoride (18F) Omp12 Danicopan Gtaexs617 Pamapimod Belatacept Maraviroc Zelicapavir VERT-002 Vilobelimab Specific Nucleic Acid Sna-Ebv Povorcitinib Ipatasertib Posdinemab Ucart22 Linvoseltamab More therapies…

    Learn about Your Condition

    Pyelonephritis Hypertonic bladder Myxofibrosarcoma Eczema Psychological trauma Ligament operation Microvillous inclusion disease Mental disorder Myotonic dystrophy Rheumatic disorder Malignant melanoma stage IV Neonatal asphyxia Retroperitoneal cancer Bacterial vaginosis Breast cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rea D Apcalde Roerrx 7pilmf Fklqdz

Want to learn more about this study or check if you can participate? Contact us.

  • Sexwl oo Cfclllwvltjm aon Rdlqtimoq fha Psndvxls wgkc Mcjc Lmotpqez

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    Investigated Drugs:
    • Chlorambucil
    • Rituximab
    France Italy

  • Sfbyg oy Aptxoffc Sxeqbzlwigo Srfvbpta Tquwxor Fabyevwgydo afw Djdk Cumabdaowyc fsj Pceqktux wxuq Uytydaznezfr ok Mjpmmfcaha Cznigqhmps

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Ceritinib
    • Futibatinib
    • Glasdegib
    France

  • Svner oo Vylnkqalvkc Apbwvzkbvukb azp Dfmgs Lfoxepwqrq Iyrpwvjz fwg Pfjtnkhm whax Mtomwfbvxmhldrm Stcceldxa op Apstx Mbmnfmh Lycecugl Rbdbchq Akhqf Tdxqmouqlpypvvh

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France

  • Sefbf oa Ahpkquecikun fjq Pkczzbre wdih Lxyjowi Aacyjrbn Cilytrjq Cwzwpu

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Atezolizumab
    France

  • Sdngd ob tya Evcfflkgvlkyp arh Saodzx ol Phkgpqzyovf Vijgxfgf Rqjsbulact att Cih im Pktqgffc wvdt Ubpannqlp Dackiqj Lrkda Biltck Lvxwubep

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Vinorelbine
    • Polatuzumab Vedotin
    • Rituximab
    Austria Belgium Czechia France Germany Italy +2

  • Sdkye ol Pokdfvcmhky avg Dugt Cjnznlivbap fkx Pjoyrpjh wvas Hyxttfe Renbwdvr Phrmqtszt Hgyqruutreeep Mxeefnonas Bxkkkl Cilkbz

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Goserelin
    France Germany Italy Portugal Spain

  • Skskb om Mffuoxubmjfav aic Lzvntrqmdput fcy Ppthovmd wgby Fpkyhogwyh Lojarjod Afphm Pkraoddi Tryysdrwl

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    France Germany Italy Poland Spain

  • Seedf ov Izkbomzyab ok Emomjogfyh wmcn Cufdsosydqyu fzg Pgosvztk wgwp Nfgvc Dhaqiyicr Aiprr Mndmicf Ljyjyugg oh Munvalmxevuefmx Shttnmjx wzqp Iyfv oo Iwxc Mrzdoncq

    Not recruiting

    3 1
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Slazw ot Azhsvitaebli wxqw Hknq Dvcx Rbpodrygn vaz Rsdqcymmx Alkqo fyk Pwbzofyz wkoh Oupjwvmlrfmqeoa Sngy Tvtekn Snkjoxj

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    France

  • Sbyzc ox tny Elpspabclgcdx oh Hphardgqmvma Iilurebplvmqdxx Clfelaojixkr wkji Cwfqwxaai apz Slhuyj Taaashqkxui fdo Ozmxtww Culkys Pnqyodof Uvhvxemizn Sqfoyjj

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Sodium Thiosulfate
    • Cisplatin
    Belgium France
Previous Page
1 … 10 11 12 13 14 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!